Logo image of KSCP

KNIGHTSCOPE INC-A (KSCP) Stock Fundamental Analysis

NASDAQ:KSCP - US49907V2016 - Common Stock

5.48 USD
-0.03 (-0.54%)
Last: 9/5/2025, 8:26:29 PM
5.48 USD
0 (0%)
Pre-Market: 9/8/2025, 4:32:49 AM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to KSCP. KSCP was compared to 84 industry peers in the Commercial Services & Supplies industry. KSCP scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. KSCP is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year KSCP has reported negative net income.
In the past year KSCP has reported a negative cash flow from operations.
In the past 5 years KSCP always reported negative net income.
KSCP had a negative operating cash flow in each of the past 5 years.
KSCP Yearly Net Income VS EBIT VS OCF VS FCFKSCP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

Looking at the Return On Assets, with a value of -107.59%, KSCP is doing worse than 91.67% of the companies in the same industry.
The Return On Equity of KSCP (-208.00%) is worse than 84.52% of its industry peers.
Industry RankSector Rank
ROA -107.59%
ROE -208%
ROIC N/A
ROA(3y)-108.69%
ROA(5y)-145.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KSCP Yearly ROA, ROE, ROICKSCP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for KSCP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KSCP Yearly Profit, Operating, Gross MarginsKSCP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800 -1K

4

2. Health

2.1 Basic Checks

KSCP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, KSCP has less shares outstanding
KSCP has less shares outstanding than it did 5 years ago.
KSCP has a worse debt/assets ratio than last year.
KSCP Yearly Shares OutstandingKSCP Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
KSCP Yearly Total Debt VS Total AssetsKSCP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

KSCP has an Altman-Z score of -10.07. This is a bad value and indicates that KSCP is not financially healthy and even has some risk of bankruptcy.
KSCP has a worse Altman-Z score (-10.07) than 86.90% of its industry peers.
KSCP has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.28, KSCP is in the better half of the industry, outperforming 64.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF N/A
Altman-Z -10.07
ROIC/WACCN/A
WACC8.48%
KSCP Yearly LT Debt VS Equity VS FCFKSCP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

2.3 Liquidity

KSCP has a Current Ratio of 1.85. This is a normal value and indicates that KSCP is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of KSCP (1.85) is better than 65.48% of its industry peers.
A Quick Ratio of 1.61 indicates that KSCP should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.61, KSCP is in the better half of the industry, outperforming 67.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.61
KSCP Yearly Current Assets VS Current LiabilitesKSCP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 57.81% over the past year.
The Revenue has decreased by -6.61% in the past year.
KSCP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 28.95% yearly.
EPS 1Y (TTM)57.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64%
Revenue 1Y (TTM)-6.61%
Revenue growth 3Y46.88%
Revenue growth 5Y28.95%
Sales Q2Q%-14.17%

3.2 Future

The Earnings Per Share is expected to grow by 29.43% on average over the next years. This is a very strong growth
Based on estimates for the next years, KSCP will show a very strong growth in Revenue. The Revenue will grow by 22.79% on average per year.
EPS Next Y59.74%
EPS Next 2Y29.43%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.92%
Revenue Next 2Y22.79%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
KSCP Yearly Revenue VS EstimatesKSCP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M
KSCP Yearly EPS VS EstimatesKSCP Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -5 -10 -15

1

4. Valuation

4.1 Price/Earnings Ratio

KSCP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year KSCP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KSCP Price Earnings VS Forward Price EarningsKSCP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KSCP Per share dataKSCP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

KSCP's earnings are expected to grow with 29.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.43%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for KSCP!.
Industry RankSector Rank
Dividend Yield N/A

KNIGHTSCOPE INC-A

NASDAQ:KSCP (9/5/2025, 8:26:29 PM)

Premarket: 5.48 0 (0%)

5.48

-0.03 (-0.54%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)08-12 2025-08-12/amc
Earnings (Next)11-14 2025-11-14
Inst Owners10.62%
Inst Owner Change-34.65%
Ins Owners0.02%
Ins Owner Change0%
Market Cap55.79M
Analysts82.22
Price Target15.64 (185.4%)
Short Float %10.53%
Short Ratio1.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.21%
Min EPS beat(2)10.15%
Max EPS beat(2)26.27%
EPS beat(4)3
Avg EPS beat(4)14.17%
Min EPS beat(4)-40.39%
Max EPS beat(4)60.65%
EPS beat(8)4
Avg EPS beat(8)-0.79%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)4.74%
Min Revenue beat(2)-5.6%
Max Revenue beat(2)15.07%
Revenue beat(4)2
Avg Revenue beat(4)2.66%
Min Revenue beat(4)-7.95%
Max Revenue beat(4)15.07%
Revenue beat(8)5
Avg Revenue beat(8)5.64%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.13%
PT rev (3m)-9.8%
EPS NQ rev (1m)12.67%
EPS NQ rev (3m)28.12%
EPS NY rev (1m)11.06%
EPS NY rev (3m)19.42%
Revenue NQ rev (1m)-7.71%
Revenue NQ rev (3m)-14.5%
Revenue NY rev (1m)-4.31%
Revenue NY rev (3m)-4.31%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.06
P/FCF N/A
P/OCF N/A
P/B 3.72
P/tB 4.65
EV/EBITDA N/A
EPS(TTM)-6.54
EYN/A
EPS(NY)-3.53
Fwd EYN/A
FCF(TTM)-2.08
FCFYN/A
OCF(TTM)-2.06
OCFYN/A
SpS1.08
BVpS1.47
TBVpS1.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -107.59%
ROE -208%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-108.69%
ROA(5y)-145.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 8.33%
Cap/Sales 2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 1.61
Altman-Z -10.07
F-Score5
WACC8.48%
ROIC/WACCN/A
Cap/Depr(3y)9.15%
Cap/Depr(5y)7.04%
Cap/Sales(3y)1.97%
Cap/Sales(5y)1.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64%
EPS Next Y59.74%
EPS Next 2Y29.43%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.61%
Revenue growth 3Y46.88%
Revenue growth 5Y28.95%
Sales Q2Q%-14.17%
Revenue Next Year11.92%
Revenue Next 2Y22.79%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year22.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y4.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2.96%
OCF growth 3YN/A
OCF growth 5YN/A